Bigatab 90mg Tablet

Bigatab 90mg Tablet is used to treat a specific type of non-small cell lung cancer (NSCLC) that has metastasized to other parts of the body. It belongs to a class of medications called kinase inhibitors, working by blocking the action of an abnormal protein that signals cancer cells to multiply, thus slowing or halting the spread of cancer cells.

• Brigatinib may interfere with hormonal contraceptives. Use non-hormonal birth control methods during treatment.
• Females should use non-hormonal contraception during treatment and for 4 months after the final dose.
• Males and their partners should use birth control during treatment and for 3 months after the final dose.

Before taking Brigatinib, inform your healthcare provider about:

• Allergies to brigatinib or its ingredients.
• Other medications, including prescription, non-prescription, vitamins, supplements, and herbal products.
• Conditions such as high blood pressure, slow heartbeat, diabetes, kidney or liver disease.
• Pregnancy plans for pregnancy, or breastfeeding.

Report any severe or unusual symptoms to your doctor promptly. Serious side effects should be reported to the FDA’s MedWatch Adverse Event Reporting program.